PAR 1.96% 25.0¢ paradigm biopharmaceuticals limited..

The Miracle of iPPS on MPS -Revisited, page-33

  1. 1,053 Posts.
    lightbulb Created with Sketch. 269


    Thanks @Denial for the presentation pdf. What were the key issues you saw with lorecivivint in their phase 3?
    Thanks
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.